Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Thromboxane biosynthesis and risk of future events in diabetes mellitus: A sub-study of the ASCEND trial.

PARISH S. et al, (2023), European Heart Journal

ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy

SAMMONS E. et al, (2023), Ophthalmology

Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model

Wu R. et al, (2023), British Journal of General Practice

Evaluation of interventions to prevent vasovagal reactions among whole blood donors: rationale and design of a large cluster randomised trial.

McMahon A. et al, (2023), Trials, 24

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration

SAMMONS E. et al, (2023), Contemporary Clinical Trials Communications

Reliability of major bleeding events in UK routine data vs clinical trial adjudicated follow-up data

MAFHAM M. et al, (2023), Heart

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial

PARISH S. et al, (2023), Trials

Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized Trials

Huo X. et al, (2023), Current Developments in Nutrition, 7

A comprehensive analysis ofAPOEgenotype effects on human brain structure in the UK Biobank

Heise V. et al, (2023)

Prediction models for individual-level healthcare costs associated with cardiovascular events in the UK

Zhou J. et al, (2022), PharmacoEconomics

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet (London, England), 400, 832 - 845

Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy

BAIGENT C. et al, (2022), The Lancet

Hospital costs associated with adverse events in people with diabetes in the UK

Keng MJ. et al, (2022), Diabetes, Obesity and Metabolism

Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial.

Song J. et al, (2022), Trials, 23

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial.

Parish S. et al, (2022), Eur Heart J

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

Decrements in health-related quality of life associated with adverse events in people with diabetes.

Keng MJ. et al, (2022), Diabetes Obes Metab, 24, 530 - 538

CALIBRATING CARDIOVASCULAR DISEASE POLICY MODEL USING LARGE COHORT DATA

Wu R. et al, (2022), VALUE IN HEALTH, 25, S16 - S16

Impact of adverse events on hospital costs and health-related quality of life in people with diabetes

Keng MJ. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186

The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized trials

Preiss D. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?